$PRPO
Precipio, Inc.

2013 Q2 Form 10-Q Financial Statement

#000104396113000006 Filed on May 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2013 Q1 2012 Q1
Revenue $7.306M $7.374M $7.206M
YoY Change -19.65% 2.33% -3.66%
Cost Of Revenue $4.333M $4.119M $4.102M
YoY Change -4.37% 0.41% 23.33%
Gross Profit $2.973M $3.255M $3.104M
YoY Change -34.83% 4.86% -25.28%
Gross Profit Margin 40.69% 44.14% 43.08%
Selling, General & Admin $4.982M $6.311M $4.994M
YoY Change -5.61% 26.37% 15.52%
% of Gross Profit 167.57% 193.89% 160.89%
Research & Development $913.0K $764.0K $549.0K
YoY Change 39.6% 39.16% -1.44%
% of Gross Profit 30.71% 23.47% 17.69%
Depreciation & Amortization $687.0K $744.0K $513.0K
YoY Change 29.14% 45.03% 3.85%
% of Gross Profit 23.11% 22.86% 16.53%
Operating Expenses $5.895M $7.075M $5.543M
YoY Change -0.62% 27.64% 13.03%
Operating Profit -$2.922M -$3.820M -$2.439M
YoY Change 113.28% 56.62% 225.2%
Interest Expense $50.00K $250.0K -$270.0K
YoY Change -93.51% -192.59% 12.5%
% of Operating Profit
Other Income/Expense, Net $0.00 $53.00K $20.00K
YoY Change -100.0% 165.0% -91.34%
Pretax Income -$2.873M -$3.520M -$2.692M
YoY Change 384.49% 30.76% -3.3%
Income Tax -$6.000K $66.00K $4.000K
% Of Pretax Income
Net Earnings -$2.867M -$3.586M -$2.696M
YoY Change 409.24% 33.01% -2.95%
Net Earnings / Revenue -39.24% -48.63% -37.41%
Basic Earnings Per Share
Diluted Earnings Per Share -$143.5M -$179.5M -$270.0M
COMMON SHARES
Basic Shares Outstanding 88.25M shares 88.23M shares 71.63M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q2 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.390M $7.730M $19.29M
YoY Change 1.43% -59.93% 508.52%
Cash & Equivalents $6.388M $7.729M $19.29M
Short-Term Investments
Other Short-Term Assets $1.083M $1.185M $1.028M
YoY Change 21.82% 15.27% 35.26%
Inventory $4.407M $4.783M $4.014M
Prepaid Expenses
Receivables $8.039M $7.897M $6.704M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $19.92M $21.59M $31.04M
YoY Change -30.92% -30.42% 111.86%
LONG-TERM ASSETS
Property, Plant & Equipment $2.151M $2.071M $1.876M
YoY Change 16.78% 10.39% 13.01%
Goodwill $6.918M $6.918M $6.440M
YoY Change 7.42% 7.42%
Intangibles $9.941M $10.36M $7.691M
YoY Change 34.39% 34.73%
Long-Term Investments
YoY Change
Other Assets $436.0K $453.0K $140.0K
YoY Change 170.81% 223.57% -6.67%
Total Long-Term Assets $19.45M $19.80M $16.15M
YoY Change 22.77% 22.65% -3.6%
TOTAL ASSETS
Total Short-Term Assets $19.92M $21.59M $31.04M
Total Long-Term Assets $19.45M $19.80M $16.15M
Total Assets $39.36M $41.40M $47.18M
YoY Change -11.88% -12.26% 50.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.748M $1.516M $1.567M
YoY Change 18.35% -3.25% 93.46%
Accrued Expenses $2.286M $2.826M $3.593M
YoY Change -41.14% -21.35% -28.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $727.0K $364.0K $6.171M
YoY Change -88.01% -94.1% 3328.33%
Total Short-Term Liabilities $7.914M $9.494M $15.62M
YoY Change -46.42% -39.23% 87.34%
LONG-TERM LIABILITIES
Long-Term Debt $7.273M $6.069M $0.00
YoY Change 440.74% -100.0%
Other Long-Term Liabilities $1.235M $1.266M $1.211M
YoY Change 8.91% 4.54% -83.37%
Total Long-Term Liabilities $8.508M $7.335M $1.211M
YoY Change 243.2% 505.7% -93.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.914M $9.494M $15.62M
Total Long-Term Liabilities $8.508M $7.335M $1.211M
Total Liabilities $18.35M $17.33M $21.28M
YoY Change -5.19% -18.57% -17.55%
SHAREHOLDERS EQUITY
Retained Earnings -$158.6M -$155.6M -$145.7M
YoY Change 8.34% 6.79%
Common Stock $887.0K $887.0K $721.0K
YoY Change 23.02% 23.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.02M $24.07M $25.90M
YoY Change
Total Liabilities & Shareholders Equity $39.36M $41.40M $47.18M
YoY Change -11.88% -12.26% 50.27%

Cashflow Statement

Concept 2013 Q2 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$2.867M -$3.586M -$2.696M
YoY Change 409.24% 33.01% -2.95%
Depreciation, Depletion And Amortization $687.0K $744.0K $513.0K
YoY Change 29.14% 45.03% 3.85%
Cash From Operating Activities -$2.360M -$3.334M -$2.760M
YoY Change -3.28% 20.8% -5511.76%
INVESTING ACTIVITIES
Capital Expenditures -$260.0K $87.00K $198.0K
YoY Change 62.5% -56.06% 130.23%
Acquisitions
YoY Change
Other Investing Activities -$30.00K $127.0K $67.00K
YoY Change -99.67% 89.55% 6600.0%
Cash From Investing Activities -$300.0K -$1.063M -$265.0K
YoY Change -96.74% 301.13% 204.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $7.570M $17.48M
YoY Change -56.7% 249657.14%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.320M $7.668M $17.35M
YoY Change -199.25% -55.8% -5751.14%
NET CHANGE
Cash From Operating Activities -2.360M -$3.334M -$2.760M
Cash From Investing Activities -300.0K -$1.063M -$265.0K
Cash From Financing Activities 1.320M $7.668M $17.35M
Net Change In Cash -1.340M $3.271M $14.32M
YoY Change -89.67% -77.16% -4276.09%
FREE CASH FLOW
Cash From Operating Activities -$2.360M -$3.334M -$2.760M
Capital Expenditures -$260.0K $87.00K $198.0K
Free Cash Flow -$2.100M -$3.421M -$2.958M
YoY Change -7.89% 15.65% 8351.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1516000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2052000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7897000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8081000 USD
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2826000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3686000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12340000 USD
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12513000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
262000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
435000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170881000 USD
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
178450000 USD
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
164000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1088000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2171000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2549000 USD
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1079000 USD
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
483000 USD
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
1203000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 USD
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000 USD
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28741938 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34668398 shares
CY2013Q1 us-gaap Assets
Assets
41398000 USD
CY2012Q4 us-gaap Assets
Assets
38791000 USD
CY2012Q1 us-gaap Assets
Assets
47184000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
21594000 USD
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2012Q4 us-gaap Assets Current
AssetsCurrent
18717000 USD
CY2013Q1 us-gaap Capital Leases Income Statement Amortization Expense
CapitalLeasesIncomeStatementAmortizationExpense
100000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7729000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4497000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4946000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19291000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3232000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
14345000 USD
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
26643676 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8300000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71645725 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49625725 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49625725 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71645725 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
721000 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
887000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2635000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3759000 USD
CY2013Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
181000 USD
CY2012Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4102000 USD
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3693000 USD
CY2013Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
6433000 USD
CY2012Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
6171000 USD
CY2013Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 USD
CY2012Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3000000 USD
CY2013Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
197000 USD
CY2012Q1 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
0 USD
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1155000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1171000 USD
CY2012Q1 us-gaap Depreciation
Depreciation
200000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
200000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
744000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
513000 USD
CY2013Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1441000 USD
CY2012Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1260000 USD
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
21000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-39000 USD
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0188
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1125000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1121000 USD
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
500000 USD
CY2012Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
800000 USD
CY2013Q1 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y
CY2013Q1 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.575
CY2013Q1 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0057
CY2012Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Sales Issuances Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements
3100000 USD
CY2012Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3100000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3253000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2805000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1700000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13615000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13569000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10362000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10764000 USD
CY2013Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
62000 USD
CY2012Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2013Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-9000 USD
CY2012Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2012Q4 us-gaap Goodwill
Goodwill
6918000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
6918000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
3681000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
3104000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3520000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2692000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 USD
CY2013Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2012Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-720000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1057000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-448000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1474000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
356000 USD
CY2012Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-292000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
128000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-212000 USD
CY2013Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1000 USD
CY2012Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-97000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
157000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
204000 USD
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10362000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10764000 USD
CY2013Q1 us-gaap Interest Paid
InterestPaid
262000 USD
CY2012Q1 us-gaap Interest Paid
InterestPaid
495000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4057000 USD
CY2013Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3725000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
5708000 USD
CY2013Q1 us-gaap Inventory Gross
InventoryGross
5394000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
5092000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
4783000 USD
CY2013Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
611000 USD
CY2011Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
511000 USD
CY2012Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
509000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
616000 USD
CY2012Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1547000 USD
CY2013Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
1542000 USD
CY2012Q1 us-gaap Inventory Write Down
InventoryWriteDown
1000 USD
CY2013Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2013Q1 us-gaap Liabilities
Liabilities
17329000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
18517000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41398000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38791000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9494000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16528000 USD
CY2013Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
364000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
6171000 USD
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6171000 USD
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6069000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10682000 USD
CY2013Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
10723000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17349000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7668000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1063000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-265000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3334000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2760000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-2696000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-3586000 USD
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2861000 USD
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3767000 USD
CY2012Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
12000 USD
CY2013Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0 USD
CY2013Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
7501000 USD
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
5543000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3820000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2439000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
800000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
900000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1000000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1100000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1300000 USD
CY2013Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
800000 USD
CY2012Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2013Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
200000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1047000 USD
CY2013Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1185000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
202000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
453000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
61000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-173000 USD
CY2012Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
104000 USD
CY2013Q1 us-gaap Other Inventory Demo
OtherInventoryDemo
127000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1067000 USD
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1067000 USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1266000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1089000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53000 USD
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000 USD
CY2012Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
67000 USD
CY2013Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
127000 USD
CY2012Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2013Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
60000 USD
CY2013Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
849000 USD
CY2012Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
198000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87000 USD
CY2012Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
165000 USD
CY2013Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
181000 USD
CY2013Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
181000 USD
CY2012Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
165000 USD
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2586205 shares
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2586205 shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
26000 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
26000 USD
CY2013Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications.</font></div><div style="line-height:120%;padding-top:18px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior year amounts have been reclassified in order to conform to the current year presentation regarding segment reporting.</font></div></div>
CY2012Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17483000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7570000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8300000 USD
CY2012Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2013Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
6433000 USD
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14584000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14530000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2071000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2190000 USD
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
474000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1581000 USD
CY2013Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
104000 USD
CY2012Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
52000 USD
CY2012Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
82000 USD
CY2013Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6171000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
764000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
549000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151789000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-155556000 USD
CY2012Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.00
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
7206000 USD
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
7374000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6737000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4994000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
273000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
164000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0577
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.09
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.008
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2852310 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.04
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
40334 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
307500 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4353167 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4620333 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.05
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.02
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.00
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.00
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.16
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.57
CY2013Q1 us-gaap Share Price
SharePrice
0.50
CY2013Q1 us-gaap Share Price
SharePrice
0.40
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M18D
CY2012Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P8Y
CY2013Q1 us-gaap Significant Purchase Commitment Remaining Minimum Amount Committed
SignificantPurchaseCommitmentRemainingMinimumAmountCommitted
2400000 USD
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
16600000 shares
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7571000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
20274000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
24069000 USD
CY2013Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. In addition, estimates and assumptions associated with the determination of the fair value of certain assets and related impairments require considerable judgment by management. Actual results could differ from the estimates and assumptions used in preparing these consolidated financial statements.</font></div></div>
CY2013Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
500000 USD
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
900000 USD
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62683527 shares
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
84003503 shares
CY2013Q1 tbio Accounts Receivable General Payment Terms
AccountsReceivableGeneralPaymentTerms
P30D
CY2013Q1 tbio Accounts Receivable International Extended Payment Terms Greater Than
AccountsReceivableInternationalExtendedPaymentTermsGreaterThan
P90D
CY2013Q1 tbio Adjustment Of Warrants Granted
AdjustmentOfWarrantsGranted
-400000 USD
CY2012Q1 tbio Adjustment Of Warrants Granted
AdjustmentOfWarrantsGranted
0 USD
CY2012Q1 tbio Class Of Warrant Or Right Exercise Term
ClassOfWarrantOrRightExerciseTerm
P5Y
CY2013Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
8300000 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
1791268 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
10091268 shares
CY2012Q1 tbio Class Of Warrant Or Right Number Of Issued Warrants Or Rights
ClassOfWarrantOrRightNumberOfIssuedWarrantsOrRights
11380000 shares
CY2013Q1 tbio Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Price Per Share
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsPricePerShare
0.75
CY2012Q1 tbio Convertible Notes Number Of Securities Called By Note
ConvertibleNotesNumberOfSecuritiesCalledByNote
3000000 shares
CY2013Q1 tbio Fair Value Assumptions Percentage Of Simulated Equity Values Below Down Round Financing Cut Off Point
FairValueAssumptionsPercentageOfSimulatedEquityValuesBelowDownRoundFinancingCutOffPoint
0.25
CY2013Q1 tbio Finite Lived Intangible Assets Amortization Expense Current Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseCurrentFiscalYear
1700000 USD
CY2013Q1 tbio Furniture Fixtures And Leasehold Impovements Gross
FurnitureFixturesAndLeaseholdImpovementsGross
3861000 USD
CY2012Q4 tbio Furniture Fixtures And Leasehold Impovements Gross
FurnitureFixturesAndLeaseholdImpovementsGross
3848000 USD
CY2013Q1 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-153000 USD
CY2012Q1 tbio Interest Income And Expense Net
InterestIncomeAndExpenseNet
-273000 USD
CY2012Q1 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
3000 USD
CY2013Q1 tbio Inventory Provision Write Offs
InventoryProvisionWriteOffs
5000 USD
CY2013Q1 tbio Issuance Of Warrants Expected Exercise Period
IssuanceOfWarrantsExpectedExercisePeriod
P3Y10M24D
CY2012Q1 tbio Other Income Expense
OtherIncomeExpense
-253000 USD
CY2013Q1 tbio Other Income Expense
OtherIncomeExpense
300000 USD
CY2013Q1 tbio Payments Of Stock Issuance Costs Reduction To Equity
PaymentsOfStockIssuanceCostsReductionToEquity
1500000 USD
CY2011Q4 tbio Proceeds From Issuance Of Common Stock And Convertable Notes
ProceedsFromIssuanceOfCommonStockAndConvertableNotes
3000000 USD
CY2012Q1 tbio Proceeds From Issuance Of Common Stock And Convertable Notes
ProceedsFromIssuanceOfCommonStockAndConvertableNotes
22000000 USD
CY2013Q1 tbio Share Based Compensation Arrangement By Share Based Payment Award Expiration Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriod
P10Y
CY2012Q1 tbio Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0164
CY2013Q1 tbio Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0407
CY2013Q1 tbio Stock Warrants Expense
StockWarrantsExpense
-400000 USD
CY2012Q1 tbio Stock Warrants Expense
StockWarrantsExpense
0 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001043961
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
88245725 shares
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
TRANSGENOMIC INC

Files In Submission

Name View Source Status
0001043961-13-000006-index-headers.html Edgar Link pending
0001043961-13-000006-index.html Edgar Link pending
0001043961-13-000006.txt Edgar Link pending
0001043961-13-000006-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbio-20130331.xml Edgar Link completed
tbio-20130331.xsd Edgar Link pending
tbio-20130331_cal.xml Edgar Link unprocessable
tbio-20130331_def.xml Edgar Link unprocessable
tbio-20130331_lab.xml Edgar Link unprocessable
tbio-20130331_pre.xml Edgar Link unprocessable
tbio-2013331x10q.htm Edgar Link pending
tbio-ex311_2013331x10q.htm Edgar Link pending
tbio-ex312_20133x31x10q.htm Edgar Link pending
tbio-ex321_2013331x10q.htm Edgar Link pending
tbio-ex322_2013331x10q.htm Edgar Link pending